Antithrombotic therapy after myocardial infarction in patients with atrial fibrillation undergoing percutaneous coronary intervention | Zendy

Gorav Batra | Zendy; Leif Friberg | Zendy; David Erlinge | Zendy; Stefan James | Zendy; Tomas Jernberg | Zendy; Bodil Svennblad | Zendy; Lars Wallentin | Zendy; Jonas Oldgren | Zendy

Open Access

Antithrombotic therapy after myocardial infarction in patients with atrial fibrillation undergoing percutaneous coronary intervention

Author(s) -

Gorav Batra,

Leif Friberg,

David Erlinge,

Stefan James,

Tomas Jernberg,

Bodil Svennblad,

Lars Wallentin,

Jonas Oldgren

Publication year - 2017

Publication title -

european heart journal - cardiovascular pharmacotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.895

H-Index - 26

eISSN - 2055-6845

pISSN - 2055-6837

DOI - 10.1093/ehjcvp/pvx033

Subject(s) - medicine , antithrombotic , cardiology , percutaneous coronary intervention , atrial fibrillation , myocardial infarction

Optimal antithrombotic therapy after percutaneous coronary intervention (PCI) in patients with myocardial infarction (MI) and atrial fibrillation is uncertain. In this study, we compared antithrombotic regimes with regard to a composite cardiovascular outcome of all-cause mortality, MI or ischaemic stroke, and major bleeds.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research